Literature DB >> 18341629

Advances in clinical research in sickle cell disease.

Ward Hagar1, Elliott Vichinsky.   

Abstract

Sickle cell disease continues to cause significant morbidity and mortality despite increases in life expectancy. This review looks at recent translational research in sickle cell disease, covering the red cell membrane, the vascular endothelium, local and systemic inflammation and the potentially pivotal role of nitric oxide as a key regulator of sickle cell complications. Clinical research reviewed includes pulmonary hypertension, which is emerging as a particularly deadly scourge of adults with any haemolytic anaemia, and newer insights into older, more established complications and treatments, such as red cell transfusions, the need for and use of iron chelation and avascular necrosis. Finally, recent studies about those factors that affect the day-to-day lives of persons with sickle cell disease, pain and neuropsychiatric functioning, are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18341629     DOI: 10.1111/j.1365-2141.2008.07097.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  11 in total

1.  Carbon-fiber microelectrode amperometry reveals sickle-cell-induced inflammation and chronic morphine effects on single mast cells.

Authors:  Benjamin M Manning; Robert P Hebbel; Kalpna Gupta; Christy L Haynes
Journal:  ACS Chem Biol       Date:  2012-01-23       Impact factor: 5.100

2.  Upper airway lymphoid tissue size in children with sickle cell disease.

Authors:  Temima Strauss; Sanghun Sin; Carole L Marcus; Thornton B A Mason; Joseph M McDonough; Julian L Allen; Jason B Caboot; Cheryl Y Bowdre; Abbas F Jawad; Kim Smith-Whitley; Kwaku Ohene-Frempong; Allan I Pack; Raanan Arens
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

3.  Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial.

Authors:  Oluwakemi Badaki-Makun; J Paul Scott; Julie A Panepinto; T Charles Casper; Cheryl A Hillery; J Michael Dean; David C Brousseau
Journal:  Pediatr Blood Cancer       Date:  2014-01-17       Impact factor: 3.167

Review 4.  Antibiotics for treating acute chest syndrome in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Lucieni O Conterno; Jennifer M Knight-Madden
Journal:  Cochrane Database Syst Rev       Date:  2015-03-06

Review 5.  Antibiotics for treating osteomyelitis in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Luis H Agreda-Pérez
Journal:  Cochrane Database Syst Rev       Date:  2016-11-14

Review 6.  Interventions for treating leg ulcers in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Jennifer M Knight-Madden; Maria José Martinez-Zapata
Journal:  Cochrane Database Syst Rev       Date:  2021-01-09

7.  Higher rates of hemolysis are not associated with albuminuria in Jamaicans with sickle cell disease.

Authors:  Monika R Asnani; Raphael A Fraser; Marvin E Reid
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

Review 8.  Interventions for treating leg ulcers in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Jennifer M Knight-Madden; Maria José Martinez-Zapata
Journal:  Cochrane Database Syst Rev       Date:  2014-12-08

9.  Sickle cell disease: acute clinical manifestations in early childhood and molecular characteristics in a group of children in Rio de Janeiro.

Authors:  Isaac Lima da Silva Filho; Georgina Severo Ribeiro; Patrícia Gomes Moura; Monica Longo Vechi; Andréa Cony Cavalcante; Maria José de Andrada-Serpa
Journal:  Rev Bras Hematol Hemoter       Date:  2012

Review 10.  Antibiotics for treating osteomyelitis in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Luis H Agreda-Pérez
Journal:  Cochrane Database Syst Rev       Date:  2019-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.